Telmisartan/Amlodipine (80/5) vs. Telmisartan/Amlodipine (40/5) vs. Amlodipine 10 or 5 in Resistant Hypertension
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The primary objectives of this trial are (a) to demonstrate that the fixed-dose combination
T40/A5 or the fixed-dose combination T80/A5 is superior in reducing blood pressure at eight
weeks compared with A5 (b) to demonstrate that the fixed-dose combination T40/A5 or the
fixed-dose combination T80/A5 is not inferior in reducing blood pressure at eight weeks
compared with A10 and (c) to demonstrate that the incidence of oedema on the fixed-dose
combination T40/A5 pooled with the fixed-dose combination T80/A5 is superior (less oedema) to
A10 in patients who fail to respond adequately to six weeks treatment with A5.